According to a recent LinkedIn post from ABM Respiratory Care, the company plans to participate in the ATS International Congress in Orlando, Fla., from May 17–20. The post highlights that ABM will be engaging with clinicians, partners, and industry figures at booth #11803, with a focus on its BiWaze Clear and BiWaze Cough airway‑clearance solutions for hospital and home care settings.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post suggests that ABM is using the conference to deepen relationships with key decision-makers in respiratory care and to generate product demos. For investors, this type of presence at a major specialty congress may indicate an emphasis on commercial adoption, clinical validation, and partnership-building, which could be relevant to the company’s growth trajectory in the respiratory devices segment.

